ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Post-transplant lymphoproliferative disorder (PTLD)"

  • 2019 American Transplant Congress

    Phylogenetic Analysis of the Epstein Barr Virus Nuclear Antigen-1 and Associated Correlates among Canadian Transplant Patients

    M. Abdulnoor1, S. Isabel1, T. Paton1, N. Khodai-Booran1, T. Schechter1, P. Birk2, T. Blydt-Hansen3, B. Foster4, S. Mital1, V. Phan5, S. Urschel6, G. Casallo1, T. Papaz1, L. Hamiwka7, S. Min1, U. Allen1

    1University of Toronto, Toronto, ON, Canada, 2University of Manitoba, Winnipeg, MB, Canada, 3University of British Columbia, Vancouver, BC, Canada, 4McGill University, Montreal, QC, Canada, 5University of Montreal, Montreal, QC, Canada, 6University of Alberta, Edmonton, AB, Canada, 7University of Calgary, Calgary, AB, Canada

    *Purpose: The effect of the genetic diversity of the Epstein-Barr virus (EBV) on clinical outcomes in the transplant setting is important to study. We examined…
  • 2019 American Transplant Congress

    Donor Derived Neoplasia: Will It Be a Risk after Clinical Pig Organ Xenotransplantation?

    A. Jagdale1, H. Iwase1, E. Klein2, D. Cooper1

    1Surgery, University of Alabama at Birmingham, Birmingham, AL, 2Surgery, University of Pittsburgh, Pittsburgh, PA

    *Purpose: The survival of the nonhuman primates with life-supporting pig kidney grafts has increased substantially (to >1 year). As clinical pig organ xenotransplantation draws closer,…
  • 2019 American Transplant Congress

    EBV+ PTLD Cell Lines Secrete Exosomes Containing microRNAs That Alter Immune Responses

    S. Syed, E. Maloney, A. Hui, O. Martinez, S. Krams

    Stanford Univ School of Med, Stanford, CA

    *Purpose: Exosomes are nanometric (50-150nm) membrane vesicles that are released, into blood and other body fluids, by most cell types. Exosomes, which are generated from…
  • 2019 American Transplant Congress

    Steadily Dropping Malignancy Rates after Pediatric Kidney Transplantation Have Now Reversed in the Most Recent Era: A Report of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS)

    V. Dharnidharka1, C. Cramer2, A. Chua3, A. Moudgil4, K. Martz5, T. Blydt-Hansen6, J. Smith7, A. Neu, on behalf of the NAPRTCS Investigators8

    1Washington University in St. Louis, Saint Louis, MO, 2Mayo Clinic, Rochester, MN, 3Duke University, Durham, NC, 4Children's National Medical Center, Washington, DC, 5Emmes Corporation, Rockville, MD, 6BC Children's Hospital, Vancouver, BC, Canada, 7Seattle Children's Hospital, Seattle, WA, 8Johns Hopkins University, Baltimore, MD

    *Purpose: In general, malignancies are very rare in children, compared to older adults. The NAPRTCS registry has collected data on children receiving kidney transplants in…
  • 2019 American Transplant Congress

    Epstein Barr Virus DNA Integration in B Cell Lymphomas of Post-Transplant Lymphoproliferative Disorder

    M. C. McPherson, O. M. Martinez

    Surgery, Division of Abdominal Transplant, Stanford University School of Medicine, Stanford, CA

    *Purpose: Epstein Barr virus-positive (EBV+) B cell lymphomas can arise in immunosuppressed individuals, such as organ transplant recipients in the context of post-transplant lymphoproliferative disorder…
  • 2019 American Transplant Congress

    Post-transplant Lymphoproliferative Disorder Following Intestine Transplantation: Contemporary Single Center Experience

    A. Zimmerman, J. Hawksworth, A. Kroemer, P. Radkani, K. Khan, S. Kaufman, N. Yazigi, S. Subramanian, T. Fishbein, C. Matsumoto

    Georgetown Transplant Institute, MedStar Georgetown University Hospital, Washington, DC

    *Purpose: The purpose of this study was to examine the characteristics and risk factors for PTLD after intestinal transplant.*Methods: Retrospective review of intestinal transplant recipients…
  • 2019 American Transplant Congress

    EBV+ PTLD in the Modern Immunosuppression Era: Role of EBV Serology and DNAemia-Preliminary Data from CTOT-C06

    O. M. Martinez1, S. M. Krams1, M. A. Robien2, M. Lapasaran1, S. D. Boyd1, B. Armstrong3, C. Twist4, K. Weinberg1, D. Gratzinger1, B. Tan1, M. Sever3, D. Ikle3, M. Brown2, D. Bernstein1, C. O. Esquivel1

    1Stanford University Sch of Med, Stanford, CA, 2NIAID/NIH, Rockville, MD, 3Rho, Chapel Hill, NC, 4Roswell Park, Buffalo, NY

    *Purpose: Post-transplant lymphoproliferative disorder (PTLD) remains a serious problem in the pediatric transplant population. The Clinical Trials of Organ Transplantation in Children (CTOT-C)-06 is an…
  • 2018 American Transplant Congress

    Genomic Modifications Associated with Epstein Barr Virus+ Post-Transplant Lymphoproliferative Disorder

    M. McPherson,1 Y. Balachandran,1 S. Boyd,2 H. Zimmermann,3 R. Trappe,3 C. Esquivel,1 S. Krams,1 O. Martinez.1

    1Department of Surgery, Stanford University School of Medicine, Stanford, CA; 2Department of Pathology, Stanford University School of Medicine, Stanford, CA; 3Department of Haematology and Oncology, DIAKO Ev. Diakonie-Krankenhaus Bremen, Bremen, Germany.

    Epstein Barr Virus (EBV) is nearly ubiquitous in the human population, yet EBV infection is typically asymptomatic. Nevertheless, immunosuppressed transplant recipients are susceptible to EBV+…
  • 2018 American Transplant Congress

    Genomic Diversity of Epstein Barr Virus in Post-Transplant Lymphoproliferative Disorder

    E. Maloney,1 V. Busque,2 S. Hui,2 S. Krams,1,2 C. Esquivel,1,2 O. Martinez.1,2

    1Stanford Immunology, Stanford University School of Medicine, Stanford, CA; 2Department of Surgery/Division of Abdominal Transplantation, Stanford University School of Medicine, Stanford, CA.

    Purpose: In transplant recipients, Epstein-Barr Virus (EBV) is associated with the development of B cell lymphomas in post-transplant lymphoproliferative disorder (PTLD). We utilized next-generation sequencing…
  • 2018 American Transplant Congress

    The MicroRNA Landscape of EBV+ and EBV- PTLD

    Y. Balachandran,1 H. Zimmermann,2 C. Esquivel,1 S. Krams,1 R. Trappe,2 O. Martinez.1

    1Transplant Immunology Laboratory/Division of Abdominal Transplant, Stanford University, Stanford; 2Department of Haematology and Oncology, DIAKO Ev. Diakonie-Krankenhaus Bremen, Bremen, Germany.

    Post-transplant lymphoproliferative disorder (PTLD) is a potentially fatal complication of organ transplantation characterized by abnormal proliferation of lymphoid cells in the setting of immunosuppression after…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 9
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences